Molecular Characterization of Membranous Nephropathy: Quo Vadis?

Fernando C Fervenza^{1

2}, Richard J Glassock^{1

2}

Affiliations

¹ Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
² Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California.

Editorial

Fernando C Fervenza et al. J Am Soc Nephrol. 2022 Jun.

. 2022 Jun;33(6):1057-1059.

doi: 10.1681/ASN.2022040395. Epub 2022 May 16.

Fernando C Fervenza^{1

2}, Richard J Glassock^{1

2}

¹ Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
² Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California.

No abstract available

Comment on

Molecular Characterization of Membranous Nephropathy.
Sealfon R, Mariani L, Avila-Casado C, Nair V, Menon R, Funk J, Wong A, Lerner G, Hayashi N, Troyanskaya O, Kretzler M, Beck LH Jr. Sealfon R, et al. J Am Soc Nephrol. 2022 Jun;33(6):1208-1221. doi: 10.1681/ASN.2021060784. Epub 2022 Apr 27. J Am Soc Nephrol. 2022. PMID: 35477557 Free PMC article.

1. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. : M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11–21, 2009 - PMC - PubMed
1. Tomas NM, Beck LH Jr, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, et al. : Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 371: 2277–2287, 2014 - PMC - PubMed
1. Caza TN, Hassen SI, Kuperman M, Sharma SG, Dvanajscak Z, Arthur J, et al. : Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis. Kidney Int 100: 171–181, 2021 - PMC - PubMed
1. Sethi S: New “antigens” in membranous nephropathy. J Am Soc Nephrol 32: 268–278, 2021 - PMC - PubMed
1. Sampson MG, Hodgin JB, Kretzler M: Defining nephrotic syndrome from an integrative genomics perspective. Pediatr Nephrol 30: 51–63, quiz 59, 2015 - PMC - PubMed